Allianz Asset Management Gmb H Bio Techne Corp Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Bio Techne Corp stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 15,098 shares of TECH stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,098

Previous 17,748 14.93%

Holding current value

$1.1 Million

Previous $1.27 Million 5.11%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$70.96 - $82.35 $188,043 - $218,227	-2,650 Reduced 14.93%	15,098 $1.21 Million
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $22,798 - $30,883	367 Added 2.11%	17,748 $1.27 Million
Q1 2024 May 13, 2024	SELL	$65.98 - $77.09 $392,515 - $458,608	-5,949 Reduced 25.5%	17,381 $1.22 Million
Q4 2023 Feb 12, 2024	BUY	$52.83 - $78.22 $280,844 - $415,817	5,316 Added 29.51%	23,330 $1.8 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $221,465 - $293,297	-3,280 Reduced 15.4%	18,014 $1.23 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $314,291 - $366,360	-4,261 Reduced 16.67%	21,294 $1.74 Million
Q1 2023 May 11, 2023	SELL	$71.62 - $86.62 $457,580 - $553,415	-6,389 Reduced 20.0%	25,555 $1.9 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $640,116 - $2.8 Million	7,935 Added 33.05%	31,944 $2.65 Million
Q3 2022 Nov 08, 2022	SELL	$282.54 - $391.85 $1.93 Million - $2.68 Million	-6,830 Reduced 22.15%	24,009 $6.82 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $5.08 Million - $7.07 Million	-15,730 Reduced 33.78%	30,839 $10.7 Million
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $2.32 Million - $3.2 Million	6,569 Added 16.42%	46,569 $20.2 Million
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $7.29 Million - $8.39 Million	15,972 Added 66.47%	40,000 $20.7 Million
Q3 2021 Nov 10, 2021	BUY	$444.87 - $538.88 $9.89 Million - $12 Million	22,241 Added 1244.6%	24,028 $11.6 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $431,120 - $501,139	1,113 Added 165.13%	1,787 $805,000
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $212,053 - $277,014	674 New	674 $257,000
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $283,540 - $345,494	-1,221 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $38,013 - $57,309	-205 Reduced 14.38%	1,221 $322,000
Q1 2020 May 14, 2020	SELL	$161.17 - $221.51 $1.06 Million - $1.46 Million	-6,577 Reduced 82.18%	1,426 $270,000
Q4 2019 Feb 13, 2020	SELL	$189.68 - $222.09 $166,918 - $195,439	-880 Reduced 9.91%	8,003 $1.76 Million
Q3 2019 Nov 13, 2019	BUY	$183.56 - $216.72 $496,346 - $586,010	2,704 Added 43.76%	8,883 $1.74 Million
Q2 2019 Aug 08, 2019	SELL	$188.72 - $215.43 $2.93 Million - $3.34 Million	-15,520 Reduced 71.52%	6,179 $1.29 Million
Q1 2019 May 13, 2019	SELL	$136.09 - $200.44 $514,692 - $758,064	-3,782 Reduced 14.84%	21,699 $4.31 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $1.39 Million - $2.13 Million	-10,467 Reduced 29.12%	25,481 $3.67 Million
Q3 2018 Nov 13, 2018	SELL	$147.44 - $204.11 $7.23 Million - $10 Million	-49,033 Reduced 57.7%	35,948 $7.34 Million
Q2 2018 Aug 13, 2018	BUY	$144.9 - $165.58 $2.52 Million - $2.88 Million	17,416 Added 25.78%	84,981 $12.6 Million
Q1 2018 May 14, 2018	BUY	$131.46 - $151.04 $3.02 Million - $3.47 Million	23,000 Added 51.61%	67,565 $10.2 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-535 Reduced 1.19%	44,565 $5.23 Million
Q1 2017 Apr 17, 2019	BUY	N/A	10,685 Added 31.05%	45,100 $4.57 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-1,100 Reduced 3.1%	34,415 $3.54 Million
Q3 2016 Apr 17, 2019	BUY	N/A	35,515	35,515 $3.85 Million

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Bio Techne Corp Transaction History